Sakura, Japan

Hideki Sawai

This inventor holds 2 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1985-1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideki Sawai. Retrieved from https://idiyas.com/inventor/hideki-sawai-a15vet71

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1985-1986

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Hideki Sawai

Introduction

Hideki Sawai is a notable inventor based in Sakura, Japan. He has made significant contributions to the field of veterinary medicine through his innovative inventions. With a total of 2 patents, his work focuses on improving animal health and growth.

Latest Patents

Sawai's latest patents include an antimycoplasmal agent for animals and a method of use for prevention and treatment of mycoplasmosis. This invention comprises an acyl peptide designed to combat mycoplasmosis in animals. His second patent is an animal growth promotant, which consists of an acyl peptide or its non-toxic salt as an active ingredient. This invention also outlines methods for promoting animal growth, improving weight gain, and enhancing feed utilization efficiency.

Career Highlights

Hideki Sawai is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in developing innovative solutions for animal health. His work has had a positive impact on veterinary practices and animal husbandry.

Collaborations

Sawai has collaborated with notable coworkers such as Hirofumi Takagi and Kiyohiko Kunugita. Their combined efforts have contributed to advancements in veterinary medicine.

Conclusion

Hideki Sawai's contributions to veterinary medicine through his patents demonstrate his commitment to improving animal health and growth. His innovative solutions continue to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…